| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCUUGGGGCCUGGGCAGCCACACUGCACGCAGGCUGGGCCGACUGAGGG… | 5414 nt | 0.4213 | |
| GCUUGGGGCCUGGGCAGCCACACUGCACGCAGGCUGGGCCGACUGAGGG… | 2263 nt | 0.4432 | |
| GCUUGGGGCCUGGGCAGCCACACUGCACGCAGGCUGGGCCGACUGAGGG… | 1957 nt | 0.4384 | |
| GCUUGGGGCCUGGGCAGCCACACUGCACGCAGGCUGGGCCGACUGAGGG… | 1873 nt | 0.4378 | |
| AGACGCUGUGGUCUCACCUGUCCUGGCAAGGGGCCUCUGCCGGCUGUUC… | 2037 nt | 0.4212 | |
| GCUUGGGGCCUGGGCAGCCACACUGCACGCAGGCUGGGCCGACUGAGGG… | 3623 nt | 0.4162 |
This gene encodes a subnuclear organelle and major component of the PML (promyelocytic leukemia)-SP100 nuclear bodies. PML and SP100 are covalently modified by the SUMO-1 modifier, which is considered crucial to nuclear body interactions. The encoded protein binds heterochromatin proteins and is thought to play a role in tumorigenesis, immunity, and gene regulation. Alternatively spliced variants have been identified for this gene; one of which encodes a high-mobility group protein. [provided by RefSeq, Aug 2011]
A study in humans demonstrated that exosomes from heat stroke patients showed significant upregulation of the SP100 mRNA, which is associated with inflammatory response, as verified by qPCR array [Li et al. DOI:10.3389/fimmu.2021.624753].